Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Inflammatory Breast Neoplasms × Drug Therapy × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 13 Breast Neoplasms 12 Neoplasms 9 Carcinoma, Squamous Cell 8 Head and Neck Neoplasms 7 Ovarian Neoplasms 6 Neoplasm Metastasis 6 Lung Neoplasms 6 Glioblastoma 6 Colorectal Neoplasms 6 Recurrence 5 Melanoma 5 Leukemia, Myeloid, Acute 5 Prostatic Neoplasms 4 Pancreatic Neoplasms 4 Lymphoma, Non-Hodgkin 4 Leukemia 4 Small Cell Lung Carcinoma 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Lymphoma, Follicular 3 Fallopian Tube Neoplasms 3 Colonic Neoplasms 3 Brain Neoplasms 3 Treatment 2 Squamous Cell Carcinoma of Head and Neck 2 Sarcoma 2 Rectal Neoplasms 2 Mouth Neoplasms 2 Mesothelioma, Malignant 2 Lymphoma, T-Cell, Peripheral 2

Interventions

Cyclophosphamide 11 Doxorubicin 7 Trastuzumab 6 Paclitaxel 6 Taxes 5 Radiotherapy 4 Epirubicin 4 Docetaxel 4 Carboplatin 4 Albumin-Bound Paclitaxel 4 pembrolizumab 3 Melphalan 3 pertuzumab 2 eribulin 2 Thiotepa 2 Tamoxifen 2 Peripheral Blood Stem Cell Transplantation 2 Lapatinib 2 Fluorouracil 2 Filgrastim 2 130-nm albumin-bound paclitaxel 2 trastuzumab biosimilar HLX02 1 talimogene laherparepvec 1 sargramostim 1 ruxolitinib 1 romidepsin 1 pazopanib 1 nintedanib 1 neratinib 1 grapiprant 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡